XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16163)	1/2/2003 12:23:58 PM
From: Edscharp	Read Replies (1) of 17367

Robert, "Ed. I hang on cause I know it works naturally. Literally. BPI could be bigger than one can imagine" Maybe, you could share your reason for optimism. I know bpi works in the test tube, but thus far evidence of in-vivo efficacy is ambiguous at best. If the effect of bpi on bacteria was zowie, we'd have seen it by now. Personally, I think it's reasonable to surmise that the body mechanisms that govern the production and antibacterial effect of bpi are far more complex than merely injecting the glop into one's veins. As for the theoretical potential of bpi, I've never doubted it. Certainly, there will always be a ready market for any medication that can tackle the problems of bacterial meningitis and sepsis which bpi has failed to do. Ed

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next